Sai Life's margin slips for a second straight quarter despite YoY gains
Revenue fell -7.95% QoQ as costs declined more slowly than sales; operating margin remained 4.16 percentage points above the Healthcare peer median.
Filed 06 Aug 2026, 22:40 IST · after market close · Sai Life Sciences Ltd (SAILIFE)
Key takeaways
- Consolidated revenue grew +11.66% YoY and operating margin expanded 2.34 percentage points, but revenue fell -7.95% sequentially.
- Sequential margin narrowed by 2.62 percentage points because expenses fell -4.54% versus a -7.95% revenue decline.
- Net profit rose +21.22% YoY with other income contributing only 3.61% of pre-tax profit, while interest expense fell -38.19%.
Price around the results
YoY growth held, but sequential momentum weakened
The consolidated business delivered +11.66% YoY revenue growth, while operating profit grew +22.38%, allowing margin to expand by 2.34 percentage points. Sequentially, revenue fell -7.95% and net profit dropped -29.70%, a sharper decline than sales. This points to weaker operating leverage in Q1FY27 after the stronger Q4FY26 outcome.
Slower cost reduction drove the QoQ margin squeeze
Expenses declined only -4.54% QoQ against the -7.95% revenue decline, narrowing operating margin by 2.62 percentage points. The YoY comparison was more favourable: expenses grew +8.20%, slower than revenue, supporting the 2.34-percentage-point margin expansion. Lower interest expense, down -38.19% YoY, also supported pre-tax profit, while the tax-rate change was only 0.07 percentage points.
Margin is below the Q3 peak but above sector median
Operating margin has declined for two consecutive quarters, from 33.76% in Q3FY26 to 29.32% in Q4FY26 and 26.70% in Q1FY27. Even so, Sai Life's margin was 4.16 percentage points above the 22.54% median for the 48 Healthcare peers that had reported the quarter. Other income was only 3.61% of pre-tax profit, so reported profit was not materially dependent on that line.
No immediate market reaction after the late filing
The consolidated results were filed after market close, so there was no current-session reaction to assess. Across the six previous result reactions, the stock rose three times and fell three times, with a median absolute move of 4.59%.
Q1FY27 at a glance
Consolidated figures as filed with NSE — cross-checked against an independent source.
| Line item | Q1FY27 | Q4FY26 | QoQ | YoY |
|---|---|---|---|---|
| Revenue | ₹554 cr | ₹602 cr | -7.95% | +11.66% |
| Other income | ₹4 cr | ₹16 cr | -77.61% | -64.24% |
| Expenses | ₹406 cr | ₹426 cr | -4.54% | +8.20% |
| Operating profit | ₹148 cr | ₹177 cr | -16.17% | +22.38% |
| Operating margin (%) | 26.70% | 29.32% | — | — |
| Interest | ₹8 cr | ₹8 cr | -2.43% | -38.19% |
| Depreciation | ₹46 cr | ₹45 cr | +1.39% | +21.79% |
| Profit before tax | ₹98 cr | ₹139 cr | -29.63% | +21.33% |
| Tax | ₹25 cr | ₹35 cr | -29.44% | +21.69% |
| Net profit | ₹73 cr | ₹104 cr | -29.70% | +21.22% |
| EPS (₹) | ₹3.46 | ₹4.93 | -29.82% | +19.31% |
Operating margin of 26.70% compares with a Healthcare sector median of 22.54% across 48 peers that have reported Q1FY27.
What to watch
- Whether consolidated operating margin holds above 26.70%.
- Whether revenue recovers from the -7.95% QoQ decline.
- Whether other income remains near 3.61% of pre-tax profit.